secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001034842-26-000007
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rigel appoints Michael P. Miller to board, effective Feb 1, 2026
----------------------------------------------------------------

- Michael P. Miller appointed to Rigel board effective Feb 1, 2026; term expires at 2027 annual meeting.
- Miller will serve on Compensation Committee; receives $50k annual retainer plus $10k for committee.
- Initial option grant of 12,000 shares under 2018 Plan; annual grants of 3,000 options + 2,500 RSUs thereafter.
- Board determined Miller is independent under applicable standards; no family relationships or transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/0001034842-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/rigl-20260201.htm
  HTML page:      https://secwatch.observer/filing/0001034842-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer